Advertisement

Behavioral Digital Therapeutics in Gastrointestinal Conditions

Where Are We Now and Where Should We Go?
Published:October 19, 2022DOI:https://doi.org/10.1016/j.gtc.2022.07.011

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Gastroenterology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jones M.P.
        • Dilley J.B.
        • Drossman D.
        • et al.
        Brain–gut connections in functional GI disorders: anatomic and physiologic relationships.
        Neurogastroenterol Motil. 2006; 18: 91-103
        • Bonaz B.L.
        • Bernstein C.N.
        Brain–gut interactions in inflammatory bowel disease.
        Gastroenterology. 2013; 144: 36-49
        • Creed F.
        • Ratcliffe J.
        • Fernandez L.
        • et al.
        Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.
        Ann Intern Med. 2001; 134: 860-868
        • Monnikes H.
        Quality of life in patients with irritable bowel syndrome.
        J Clin Gastroenterol. 2011; 45: S98-S101
        • Frandemark A.
        • Tornblom H.
        • Jakobsson S.
        • et al.
        Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem.
        Am J Gastroenterol. 2018; 113: 1540-1549
        • Barberio B.
        • Zamani M.
        • Black C.J.
        • et al.
        Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis.
        Lancet Gastroenterol Hepatol. 2021; 6: 359-370
        • Szigethy E.M.
        • Allen J.I.
        • Reiss M.
        • et al.
        White paper AGA: the impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease.
        Clin Gastroenterol Hepatol. 2017; 15: 986-997
        • Nguyen N.H.
        • Khera R.
        • Ohno-Machado L.
        • et al.
        Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases.
        Clin Gastroenterol Hepatol. 2018; 16: 1284-1292.e30
      1. 2022 access to care survey results: prepared for the national council for mental wellbeing by the harris poll.
        (Available at:) (Accessed July 13, 2022)
        • Kosinski L.
        • Brill J.V.
        • Sorensen M.
        • et al.
        Project sonar: reduction in cost of care in an attributed cohort of patients with Crohn’s disease.
        Gastroenterology. 2016; 150: S173
        • Wang P.A.-O.X.
        • Berzin T.A.-O.
        • Glissen Brown J.A.-O.
        • et al.
        Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study.
        Gut. 2019; 68: 1813-1819
        • Atreja A.
        • Khan S.
        • Szigethy E.
        • et al.
        Improved quality of care for IBD patients using HealthPROMISE app: a randomized, control trial.
        Am J Gastroenterol. 2018; 113: S1
        • Gibbons R.D.
        • Weiss D.J.
        • Frank E.
        • et al.
        Computerized adaptive diagnosis and testing of mental health disorders.
        Annu Rev Clin Psychol. 2016; 12: 83-104
        • Karpin J.
        • Rodriguez T.G.
        • Traboulsi C.
        • et al.
        Assessment of comorbid depression and anxiety in inflammatory bowel disease using adaptive testing technology.
        Crohns Colitis. 2021; 360: 3
        • Bonnert M.
        • Olen O.
        • Lalouni M.
        • et al.
        Internet-delivered cognitive behavior therapy for adolescents with irritable bowel syndrome: a randomized controlled trial.
        Am J Gastroenterol. 2017; 112: 152-162
        • Ljotsson B.
        • Falk L.
        • Vesterlund A.W.
        • et al.
        Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial.
        Behav Res Ther. 2010; 48: 531-539
        • Karyotaki E.
        • Riper H.
        • Twisk J.
        • et al.
        Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms: a meta-analysis of individual participant data.
        JAMA Psychiatry. 2017; 74: 351-359
        • Everitt H.A.
        • Landau S.
        • O'Reilly G.
        • et al.
        Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
        Gut. 2019; 68: 1613-1623
        • Szigethy E.
        • Tansel A.
        • Pavlick A.N.
        • et al.
        A coached digital cognitive behavioral intervention reduces anxiety and depression in adults with functional gastrointestinal disorders.
        Clin Transl Gastroenterol. 2021; 12: e00436
        • Szigethy E.
        • Oser M.
        • Regueiro M.D.
        • et al.
        Feasibility of mobile CBT for generalized anxiety among IBD patients in medical home.
        Gastroenterology. 2017; 152: S844
        • Keefer L.
        • Palsson O.S.
        • Pandolfino J.E.
        Best practice update: incorporating psychogastroenterology into management of digestive disorders.
        Gastroenterology. 2018; 154: 1249-1257
        • Ford A.C.
        • Lacy B.E.
        • Harris L.A.
        • et al.
        Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis.
        Am J Gastroenterol. 2019; 114: 21-39
        • Keefer L.
        • Taft T.H.
        • Kiebles J.L.
        • et al.
        Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis.
        Aliment Pharmacol Ther. 2013; 38: 761-771
        • Calvert E.L.
        • Houghton L.A.
        • Cooper P.
        • et al.
        Long-term improvement in functional dyspepsia using hypnotherapy.
        Gastroenterology. 2002; 123: 1778-1785
        • Flik C.E.
        • Laan W.
        • Zuithoff N.P.A.
        • et al.
        Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.
        Lancet Gastroenterol Hepatol. 2019; 4: 20-31
        • Palsson O.S.
        Hypnosis treatment of gastrointestinal disorders: a comprehensive review of the empirical evidence.
        Am J Clin Hypn. 2015; 58: 134-158
        • Mohr D.C.
        • Azocar F.
        • Bertagnolli A.
        • et al.
        Banbury forum consensus statement on the path forward for digital mental health treatment.
        Psychiatr Serv. 2021; 72: 677-683
        • Riehl M.E.
        Limited access to integral care: digital therapeutics show promise of scalable solutions to behavioral interventions.
        Clin Transl Gastroenterol. 2022; 13: e00444
        • Carlo A.D.
        • Hosseini Ghomi R.
        • Renn B.N.
        • et al.
        By the numbers: ratings and utilization of behavioral health mobile applications.
        NPJ Digit Med. 2019; 2: 54
      2. International Medical Device Regulators Forum Software as a Medical Device (SaMD) Working Group. (2014). Software as a Medical Device: Possible Framework for Risk Categorization and Corresponding Considerations. International Medical Device Regulators Forum. Available at: https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf.

      3. The app evaluation model: american psychiatric association.
        (Available at:)
        • Kumbhare S.V.
        • Francis-Lyon P.A.
        • Kachru D.
        • et al.
        Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study.
        Front Microbiol. 2022; 13: 826916
        • Hoermann S.
        • McCabe K.L.
        • Milne D.N.
        • et al.
        Application of synchronous text-based dialogue systems in mental health interventions: systematic review.
        J Med Internet Res. 2017; 19: e267
        • Fitzpatrick K.K.
        • Darcy A.
        • Vierhile M.
        Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): a randomized controlled trial.
        JMIR Ment Health. 2017; 4: e19
        • Prodan A.
        • Deimel L.
        • Ahlqvist J.
        • et al.
        Success factors for scaling up the adoption of digital therapeutics towards the realization of P5 medicine.
        Front Med (Lausanne). 2022; 9: 854665